A Six Week Pharmacokinetic Study of TP-03 in Healthy Subjects
Clinical trial NCT05138861 · COMPLETED
Trial details
- NCT number
- NCT05138861
- Sponsor
- Tarsus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-09
- Primary completion
- 2021-09-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.